Unknown

Dataset Information

0

Clinical significance of serum autoantibodies in patients with NAFLD: results from the nonalcoholic steatohepatitis clinical research network.


ABSTRACT: Some studies have suggested that autoantibodies might define a subcategory and phenotype of nonalcoholic fatty liver disease (NAFLD) associated with advanced histological features. We evaluated the relationship between the presence of serum autoantibodies and liver histology in a large cohort of well-characterized patients with NAFLD.A total of 864 NAFLD patients participating in two prospective multicentre clinical studies underwent testing for serum autoantibodies within 24 months of a liver biopsy. Liver histology was compared between the patients with and without ANA ? 1:160 or ASMA ? 1:40 or both.Autoantibodies were present in 182 patients (21%). There was no difference in age, gender, race, body mass index (BMI), homeostasis model assessment of insulin resistance (HOMA-IR), or history of diabetes between the two groups. Biopsies in subjects with autoantibodies were less likely to have moderate-to-severe steatosis (i.e., >33%) compared to controls (57.1 vs. 43.0%, P value = 0.0006). Lobular inflammation (46.7 vs. 47.5%), ballooning degeneration (38.5 vs. 42.5%), and advanced fibrosis (33.2 vs. 29.3%) were not different between the two groups. Histologic evidence of 'definite' NASH did not differ significantly between the two groups (55.5 vs. 58.9%). After adjusting for age, gender, BMI, race, and diabetes, the presence of autoantibodies was independently associated with lower prevalence of moderate-to-severe steatosis [odds ratio (OR), 0.58; 95% confidence interval (CI), 0.41-0.82; P = 0.01].Autoantibodies are frequently positive in NAFLD in the absence of autoimmune hepatitis and their occurrence is not associated with more advanced histologic features.

SUBMITTER: Vuppalanchi R 

PROVIDER: S-EPMC3511661 | biostudies-literature | 2012 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

Clinical significance of serum autoantibodies in patients with NAFLD: results from the nonalcoholic steatohepatitis clinical research network.

Vuppalanchi Raj R   Gould Robert J RJ   Wilson Laura A LA   Unalp-Arida Aynur A   Cummings Oscar W OW   Chalasani Naga N   Kowdley Kris V KV  

Hepatology international 20110510 1


<h4>Purpose</h4>Some studies have suggested that autoantibodies might define a subcategory and phenotype of nonalcoholic fatty liver disease (NAFLD) associated with advanced histological features. We evaluated the relationship between the presence of serum autoantibodies and liver histology in a large cohort of well-characterized patients with NAFLD.<h4>Methods</h4>A total of 864 NAFLD patients participating in two prospective multicentre clinical studies underwent testing for serum autoantibodi  ...[more]

Similar Datasets

| S-EPMC2928479 | biostudies-literature
| S-EPMC6570584 | biostudies-literature
| S-EPMC2692572 | biostudies-literature
| S-EPMC3653086 | biostudies-other
| S-EPMC6721710 | biostudies-literature
| S-EPMC6049064 | biostudies-literature
| S-EPMC8046622 | biostudies-literature
| S-EPMC4921726 | biostudies-literature
| S-EPMC10524415 | biostudies-literature
| S-EPMC7738099 | biostudies-literature